United States: $176 Million Jury Verdict Sunk By Patents' Insufficient Invention Disclosure—Teva v. Eli Lilly & Co - YMF Law Tokyo
Wednesday, 13 March 2024
. . . trial testimony established that "there are a ‘mind-bogglingly large' number of antibodies that could potentially fit within the scope" of the patent claims but "the actual number is not ‘knowable. . . .'"
. . . trial testimony established that "there are a ‘mind-bogglingly large' number of antibodies that could potentially fit within the scope" of the patent claims but "the actual number is not ‘knowable. . . .'"
|
||||
You Might LikeRelated videos from verified sources
|